2 minute read
Abbreviations
ANSM ANVISA API ASN AUD BBBEE CER DCA DPML-CI EDQM EFDA EMA EUR FDF GBP GFDA GMP GRA HPB HPRA ICHA IRA ISO KFDA Kℓ KvH LAsD LRA MCAZ MOH – DRC NAFDAC NHEPS OHSAS PMDA PMPB PPB Russian MoIT Saudi FDA SAHPRA SED TGA TMDA TRA UNDA USD US FDA WHO ZAMRA ZAR
French National Agency for Medicinal and Health Product Safety Brazilian National Health Surveillance Agency Active pharmaceutical ingredient Nuclear Safety Authority for E-beam Australian Dollar Broad-based black economic empowerment Constant exchange rate Drug Control Administration – India Directorate of Pharmacy, Medicines and Laboratories – Ivory Coast European Directorate for the Quality of Medicines Ethiopian Food and Drug Administration European Medicines Agency Euro Finished dose form British Pound Ghanian Food and Drugs Authority Good Manufacturing Practice German Regulatory Authority Health Protection Branch (Canada) Health Products Regulatory Authority (Ireland) Ivory Coast Health Authority Israeli Regulatory Authorities International Organisation for Standardisation Korean Food and Drug Administration Kilolitre Kilo vessel hours Local vs Federal Agencies Libyan Regulatory Authorities Medicines Control Agency of Zimbabwe Ministry of Health – Democratic Republic of Congo Nigerian National Agency for Food and Drug Administration and Control Normalised headline earnings per share Occupational Health and Safety Management Systems Japanese Pharmaceutical and Medical Device Agency Malawian Pharmacy, Medicines and Poisons Board Kenyan Pharmacy and Poisons Board Ministry of Industry and Trade of the Russian Federation Saudi Food and Drug Authority South African Health Products Regulatory Authority Socio-economic development Australian Therapeutic Goods Administration Tanzania Medicines and Medical Devices Authority Turkish Regulatory Authority Ugandan National Drug Authority United States Dollar United States Food and Drug Administration World Health Organisation Zambia Medicine Regulatory Authority South African Rand
Disclaimer
We may make statements that are not historical facts and relate to analyses and other information based on forecasts of future results and estimates of amounts not yet determinable. These are forward looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “prospects”, “believe”, “anticipate”, “expect”, “intend”, “seek”, “will”, “plan”, “indicate”, “could”, “may”, “endeavour” and “project” and similar expressions are intended to identify such forward looking statements, but are not the exclusive means of identifying such statements. By their very nature, forward looking statements involve inherent risks and uncertainties, both general and specific, and there are risks that predictions, forecasts, projections and other forward looking statements will not be achieved. If one or more of these risks materialise, or should underlying assumptions prove incorrect, actual results may be very different from those anticipated. The factors that could cause our actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward looking statements are discussed in each year’s Annual Report. Forward looking statements apply only as of the date on which they are made, and we do not undertake other than in terms of the Listings Requirements of the JSE Limited, any obligation to update or revise any of them, whether as a result of new information, future events or otherwise.
Aspen Holdings Head Office
Durban, South Africa Aspen Place, 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge Tel: +27 31 580 8600
